Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adherence to Dyslipidemia Therapy: Harnessing Evidence From Randomized Evaluations in AtheroSclerotic CardioVascular Disease (ADHERE-ASCVD)

NCT07522645 is registered in ClinicalTrials.gov with Kaiser Permanente as lead sponsor.

NCT NCT07522645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07522645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adherence to Dyslipidemia Therapy: Harnessing Evidence From Randomized Evaluations in AtheroSclerotic CardioVascular Disease (ADHERE-ASCVD)
Lead sponsor
Kaiser Permanente
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 14, 2026
Completion date
December 31, 2028
Enrollment
22,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ascvd, diabetes